Clinical significance of antinuclear antibodies in systemic rheumatic diseases.
Autoantibodies directed to intracellular antigens can be detected in many systemic rheumatic diseases. In this review, we discuss the clinical significance of antinuclear antibodies (ANA) associated with systemic lupus erythematosus (SLE), Slögren's syndrome, scleroderma and polymyositis/dermatomyositis, the immunogenetic factors associated with these four autoimmune diseases, and the possible role of autoantibodies in the etiopathogenesis of autoimmune disease. The antibodies associated with systemic rheumatic diseases serve as important tools in the initial diagnosis, and they are also useful in the evaluation of prognosis. However, for correct conclusions, the autoantibody findings should be carefully considered and interpreted in clinical context.
Hietarinta
M
M
Turku Immunology Centre, Department of Medicine and Medical Microbiology, Turku University, Finland.
Lassila
O
O
D000974:Antibodies, Antinuclear / Q000032:analysis*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D017285:Polymyositis / Q000276:immunology*; D012216:Rheumatic Diseases / Q000276:immunology; D012595:Scleroderma, Systemic / Q000276:immunology*; D012859:Sjogren's Syndrome / Q000276:immunology*
D000974:Antibodies, Antinuclear